EUROPEAN JOURNAL OF
PHARMACEUTICAL AND MEDICAL RESEARCH

( An ISO 9001:2015 Certified International Journal )

An International Peer Reviewed Journal for Pharmaceutical, Medical & Biological Sciences

An Official Publication of Society for Advance Healthcare Research (Reg. No. : 01/01/01/31674/16)

European Journal of Pharmaceutical and Medical Research (EJPMR) has indexed with various reputed international bodies like : Google Scholar , Indian Science Publications , InfoBase Index (In Process) , SOCOLAR, China , Research Bible, Fuchu, Tokyo. JAPAN , International Society for Research activity (ISRA) , Scientific Indexing Services (SIS) , Polish Scholarly Bibliography , Global Impact Factor (GIF) (Under Process) , Universal Impact Factor , International Scientific Indexing (ISI), UAE  , Index Copernicus , CAS (A Division of American Chemical Society) USA (Under Process) , Directory of Open Access Journal (DOAJ, Sweden, in process) , UDLedge Science Citation Index , CiteFactor , Directory Of Research Journal Indexing (DRJI) , Indian citation Index (ICI) , Journal Index (JI, Under Process) , Directory of abstract indexing for Journals (DAIJ) , Open Access Journals (Under Process) , Impact Factor Services For International Journals (IFSIJ) , Cosmos Impact Factor , Jour Informatics (Under Process) , Eurasian Scientific Journal Index (ESJI) , International Innovative Journal Impact Factor (IIJIF) , Science Library Index, Dubai, United Arab Emirates , Pubmed Database [NLM ID: 101669306] (Under Process) , IP Indexing (IP Value 2.40) , Web of Science Group (Under Process) , Directory of Research Journals Indexing , Scholar Article Journal Index (SAJI) , International Scientific Indexing ( ISI ) , Scope Database , Academia , 

 ISSN (O) : 2394-3211

 ISSN (P) : 3051-2573

Impact Factor: 7.065

 ICV - 79.57

Abstract

PREVALANCE OF GLUCOSE-6-PHOSPHATE DEHYDROGENASE DIFICIENCY IN CHILDREN WITH ACUTE HEMOLYSIS AT LATAKIA UNIVERSITY HOSPITAL

Sarab Gamee*, Souad Sakkour and Abdulmonem Ghanem

ABSTRACT

Introduction: G6PD deficiency is one of the most common human enzyme defects, affecting more than 500 million people worldwide. It is an X-linked genetic disease that affects males more than females. Severe hemolytic anemia is the most important clinical manifestation of G6PD deficiency, which may be caused by several inciting factors, the most important of which is the consumption of beans. Objectives of the Research: Primary Objective: To determine the prevalence of G6PD deficiency as a cause of acute hemolysis in children attending the emergency department aged 6 months to 12 years. Secondary Objectives: Determine the severity of the deficiency. • Identify the most important factors that trigger hemolysis. • Identify the most common clinical manifestations. Methods: A descriptive-cross-sectional observational study during the period from( March 2024 to March 2025) at Lattakia University Hospital- Syria. The study included 115 children who had acute hemolysis and met the inclusion criteria. A detailed medical history was taken and G6PD levels were measured 4 months after the occurrence of a hemolytic episode. Results: Among 115 children with acute hemolysis, cases (57.4%) were diagnosed as G6PD deficiency. Most cases were in males (75.8%) compared to (24.2%) in females. Fava beans were the most common triggering factor for the hemolytic episode. Pallor, jaundice, and dark urine were the most common clinical symptoms. Moderate enzyme deficiency was the most common (62.1%). Conclusion: G6PD deficiency is an important cause of acute hemolysis in children. Diagnosis and appropriate preventive measures should be established.

Keywords: G6PD enzyme, G6PD deficiency, hemolytic anemia, favism.


[Full Text Article] [Download Certificate]

Citation

  All Since 2019
 Citation  3086  2560
 h-index  18  17
 i10-index  64  44

INDEXING

NEWS & UPDATION

  • New Issue Published

    Its Our pleasure to inform you that, EJPMR 1 August 2025 Issue has been Published, Kindly check it on https://www.ejpmr.com/issue

  • EJPMR: AUGUST ISSUE PUBLISHED

    AUGUST 2025 issue has been successfully launched on AUGUST 2025.

  • EJPMR New Impact Factor

    EJPMR Impact Factor has been Increased to 7.065 for Year 2024.

  • Index Copernicus Value

    EJPMR Received Index Copernicus Value 79.57, due to High Quality Publication in EJPMR at International Level

  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.

    .

  • Article Invited for Publication

    Article are invited for publication in EJPMR Coming Issue

Google Scholar Indian Science Publications InfoBase Index (In Process) SOCOLAR, China Research Bible, Fuchu, Tokyo. JAPAN International Society for Research activity (ISRA) Scientific Indexing Services (SIS) Polish Scholarly Bibliography Global Impact Factor (GIF) (Under Process) Universal Impact Factor International Scientific Indexing (ISI), UAE Index Copernicus CAS (A Division of American Chemical Society) USA (Under Process) Directory of Open Access Journal (DOAJ, Sweden, in process) UDLedge Science Citation Index CiteFactor Directory Of Research Journal Indexing (DRJI) Indian citation Index (ICI) Journal Index (JI, Under Process) Directory of abstract indexing for Journals (DAIJ) Open Access Journals (Under Process) Impact Factor Services For International Journals (IFSIJ) Cosmos Impact Factor Jour Informatics (Under Process) Eurasian Scientific Journal Index (ESJI) International Innovative Journal Impact Factor (IIJIF) Science Library Index, Dubai, United Arab Emirates Pubmed Database [NLM ID: 101669306] (Under Process) IP Indexing (IP Value 2.40) Web of Science Group (Under Process) Directory of Research Journals Indexing Scholar Article Journal Index (SAJI) International Scientific Indexing ( ISI ) Scope Database Academia

Best Paper Awards

European Journal of Biomedical and Pharmaceutical Sciences (EJBPS) will give best paper award in every issue in the form of money along witcertificate to promote resear activity of scholar.

Best Article of current issue :

Dr. Kartik Neog
Download Article : Click here